AKT1 and non-small cell lung carcinoma: In a study conducted by Cao et al., it was found that the reduced expression of miR-19a in NSCLC cells contributed to the emergence of resistance to gefitinib and the EMT by regulating the expression of c-Met, AKT, and ERK signaling pathways [78].